Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study
血液病和肿瘤门诊患者对SARS-CoV-2疫苗初次接种和加强接种体液免疫反应不良的危险因素——COVIDOUT研究
期刊:Cancer Cell
影响因子:44.5
doi:10.1016/j.ccell.2022.04.016
Schönlein, Martin; Wrage, Victoria; Ghandili, Susanne; Mellinghoff, Sibylle C; Brehm, Thomas Theo; Leypoldt, Lisa B; Utz, Nils; Schrader, Roland M; Alsdorf, Winfried; Börschel, Niklas; Bußmann, Lara; Schönrock, Martin; Perlick, Dorothea; Schön, Gerhard; Verpoort, Karl; Lütgehetmann, Marc; Schulze Zur Wiesch, Julian; Weisel, Katja C; Bokemeyer, Carsten; Schafhausen, Philippe; Sinn, Marianne
SARS-CoV-2
肿瘤
IDO
肿瘤免疫
免疫/内分泌